What Should You Do When You Realize the Ethically Approved Study Is No Longer the Ethically Right Study to Continue?

What if a Study That Was Ethically Acceptable at Approval Is No Longer Acceptable in Practice?

A researcher receives ethics approval to study how university students use an AI-powered learning platform. The approved protocol includes voluntary participation, informed consent, and safeguards for protecting student information.

Several weeks into data collection, the researcher discovers that the platform's activity logs contain more identifiable information than originally anticipated. Students' interactions may reveal sensitive learning difficulties, and a planned system update could expand access to those records.

The research team has complied with the approved procedures. Nevertheless, the assumptions underlying the original ethical assessment may no longer hold.

Should the researcher continue because the institution already approved the study? Should data collection stop immediately? Or can the protocol be modified while preserving the research objective?

Ethical approval is granted under particular conditions. The difficult question is what researchers should do when those conditions change.

Reassess the Study When New Information Undermines Its Ethical Justification

Understanding Why Ethical Approval Must Be Reconsidered as Research Develops

Why Does Ethics Approval Not Guarantee Continuing Ethical Acceptability?

Research ethics review evaluates a proposed study using the information available at the time of assessment. Reviewers consider the research objectives, participant population, foreseeable risks, consent arrangements, and proposed safeguards.

However, research takes place under conditions that may change.

New evidence may reveal previously unrecognized risks. A participant population may become more vulnerable because of external circumstances. An intervention may produce unexpected adverse effects. Data collection technologies may change how information is stored, accessed, or disclosed.

The World Medical Association's Declaration of Helsinki requires researchers to monitor risks and burdens throughout medical research and to consider whether a study should continue, be modified, or stop when circumstances warrant reassessment.

Similarly, the United States Common Rule establishes requirements concerning institutional review, changes to approved research, and reporting of specified unanticipated problems.

These requirements do not apply identically to every research project or jurisdiction. Nevertheless, the underlying ethical principle is broader: approval does not remove the researcher's continuing responsibility to evaluate participant welfare.

What Types of Changes Can Make an Approved Study Ethically Problematic?

Not every change requires abandoning a study. The significance depends on whether the development materially affects the assumptions supporting the original ethical assessment.

Researchers should distinguish a change in circumstances from a newly discovered problem that existed from the beginning. Both may require action, but the chronology matters for understanding what occurred and whether earlier data collection was affected.

What Is an Unanticipated Problem Involving Risks to Participants or Others?

In United States human-subjects research oversight, an unanticipated problem involving risks to subjects or others has a specific regulatory significance.

Office for Human Research Protections guidance describes an unanticipated problem as an incident, experience, or outcome that is unexpected in nature, severity, or frequency; related or possibly related to research participation; and suggests that the research places participants or others at greater risk of harm than previously recognized.

Not every adverse event meets this definition, and not every unanticipated problem involves an actual injury.

For example, an unexpected disclosure of identifiable research information may increase privacy risks even when no participant has yet reported harm.

Researchers should follow the definitions, reporting pathways, and timelines applicable to their own studies. Institutional and regulatory requirements may differ, particularly outside the United States.

How Do You Know Whether a New Risk Is Serious Enough to Require Action?

Researchers should examine whether new information changes the likelihood, severity, duration, or distribution of foreseeable harms.

A minor inconvenience may require a limited procedural adjustment. Evidence of a credible threat to participant safety or a substantial confidentiality breach may require immediate protective measures.

The assessment should consider how many participants may be affected, whether exposure is continuing, whether the consequences are reversible, and whether existing safeguards remain effective.

Researchers should avoid waiting for actual harm when credible evidence indicates that serious harm may occur.

However, uncertainty alone does not always require stopping every research activity. The response should be proportionate to the risk and consistent with applicable requirements.

Where the ethical implications remain difficult to determine, independent ethical consultation may help clarify the appropriate response.

What Is the Difference Between Modifying, Suspending, and Discontinuing Research?

These responses are not interchangeable. A temporary suspension may preserve the possibility of resuming research after appropriate safeguards are established. Termination may be necessary when the underlying ethical problem cannot be adequately resolved.

The scope of a suspension also matters. Researchers may need to stop recruitment or a particular intervention while continuing necessary participant safety monitoring, subject to applicable requirements.

Can Researchers Change an Approved Protocol Without Prior Authorization?

Ordinarily, substantive changes to approved human-participant research require review and authorization under the applicable institutional framework before implementation.

Under 45 CFR 46.108(a)(3)(iii), changes in approved research generally may not be initiated without prior institutional review board review and approval, except when necessary to eliminate apparent immediate hazards to participants.

This exception should not be interpreted as general permission to redesign a study without approval.

For example, immediately disabling an unsafe data collection feature may be necessary to prevent ongoing exposure. Permanently replacing the approved data collection method may require a formal amendment.

Researchers should document urgent actions, notify the appropriate oversight body as required, and obtain authorization for continuing modifications.

Different jurisdictions and research classifications may have different procedures. Investigators must verify the rules governing their projects.

When Should Participants Be Told That the Study Has Changed?

Participants should receive information that is material to their decision about continuing participation, subject to applicable consent and reporting requirements.

New information about risks, intervention effects, confidentiality limitations, or participation demands may require revised information materials or renewed consent.

The appropriate communication depends on the nature of the change and whether it affects participants who are currently enrolled, have completed participation, or may be recruited later.

Researchers should not assume that a consent form signed at enrollment authorizes every subsequent change.

At the same time, communication must be accurate. Investigators should distinguish confirmed findings from preliminary concerns and avoid creating unnecessary alarm through unsupported statements.

The ethics committee or other authorized body may specify how and when participants should be informed.

What if Continuing the Study Could Cause Harm but Stopping Could Also Harm Participants?

Stopping research is not always ethically neutral.

Participants may depend on study-related monitoring, clinical follow-up, educational support, or other arrangements. Abruptly ending those activities could create additional risks or burdens.

Researchers should therefore consider the consequences of both continuation and discontinuation.

In a clinical study, stopping an intervention may require a transition plan and appropriate medical follow-up. In an educational intervention, discontinuation may require arrangements that avoid unnecessary disruption to students' learning.

These responsibilities depend on the study, participant expectations, institutional commitments, and applicable regulations.

The fact that stopping may create difficulties does not justify continuing an unacceptable procedure. It means that the stopping process itself should be designed responsibly.

This distinction is particularly important when ending a research project becomes the ethically preferable decision.

Can a Study Become Unethical Because Its Scientific Value Has Disappeared?

Yes. A study may become difficult to justify when new evidence or circumstances substantially undermine its capacity to produce useful knowledge.

For example, severe data loss, systematic measurement failure, or an intervention that no longer corresponds to the research question may prevent the study from generating interpretable findings.

Continuing to impose participant burdens without a credible prospect of scientific or social value may be ethically problematic.

However, a disappointing preliminary result does not automatically mean the study lacks value. Null findings, unexpected patterns, and failed hypotheses can still contribute important evidence when the design remains valid.

Researchers should distinguish a genuine loss of scientific validity from dissatisfaction with the direction of the results.

Where the problem can be addressed through an ethically acceptable redesign, the methodological consequences of the ethical modification should be assessed explicitly.

Who Has Authority to Suspend or Terminate a Study?

Authority depends on the regulatory and institutional framework.

Investigators may have immediate responsibilities to protect participants and may decide to pause activities within their authority. Research ethics committees, institutional officials, sponsors, regulators, or independent monitoring bodies may also possess formal suspension or termination powers.

Under the United States Common Rule, institutional review boards have authority to suspend or terminate approval of research that is not conducted according to their requirements or that has been associated with unexpected serious harm.

Researchers should distinguish their duty to take immediate protective action from the formal authority to modify or terminate an approval.

Where responsibilities overlap, communication should be prompt and documented.

What Should Happen to Data Already Collected?

Suspension or termination does not automatically require destruction of previously collected research data.

The appropriate response depends on consent conditions, legal obligations, data retention requirements, the nature of the ethical problem, and directions from the relevant oversight authority.

If the concern involves unauthorized collection or disclosure, researchers may need to restrict access, preserve evidence of what occurred, and obtain instructions before further processing or deletion.

Researchers should not destroy records merely to eliminate evidence of a problem.

Where continued use of the data is ethically or legally restricted, publication plans may also need revision.

The reasoning behind consequential decisions should be preserved through appropriate ethical decision documentation.

What if the Ethics Committee Disagrees With the Researcher's Concerns?

Disagreement should be addressed through the institution's established procedures.

Researchers should present the new evidence, explain the potential consequences, and identify the safeguards or changes they consider necessary.

Where the concern is not an immediate emergency, clarification or additional review may help resolve differences in risk assessment.

If serious concerns remain unresolved, researchers may seek advice from other authorized institutional, regulatory, or professional bodies as appropriate.

Investigators should not assume that a favorable committee decision removes all professional responsibility. Equally, personal disagreement does not authorize them to disregard binding institutional requirements.

The objective is to reach a defensible response through the appropriate governance process while preventing avoidable harm.

When New Privacy Risks Make an Approved Learning Analytics Study Unsafe

The appropriate decision depends on the actual exposure, the sensitivity of the information, the effectiveness of available safeguards, and applicable institutional and legal requirements.

The original approval remains relevant as part of the research record, but it does not justify ignoring a newly identified privacy problem.

Equally, the discovery does not automatically require permanent termination if the problem can be responsibly corrected.

Common Misconceptions About Reconsidering Approved Research

How to Decide Whether an Approved Study Should Continue, Change, or Stop

Begin by identifying the new information and determining whether it materially changes the study's ethical assessment.

Consider whether participants face ongoing exposure, whether immediate protective action is necessary, and which reporting or consultation requirements apply.

Then evaluate whether the research can continue under modified conditions without undermining its scientific value or participant protections.

Researchers should not treat continuation as the default merely because approval, funding, or data collection is already underway.

At the same time, they should avoid assuming that every new concern requires permanent termination.

The ethically appropriate response should be proportionate, supported by available evidence, and consistent with the applicable governance framework.

Before Continuing a Study After a Significant Ethical Concern Emerges

Frequently Asked Questions About Reassessing Approved Research

Ethics Approval Must Be Reconsidered When the Conditions Supporting It Change

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.